InvestorsHub on MSN
Biogen stock edges higher after Q4 beat and upbeat 2026 earnings guidance
Biogen Inc. (NASDAQ:BIIB) delivered stronger-than-expected results for the fourth quarter of 2025 and paired them with a confident profit outlook for 2026, lifting its shares modestly higher following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results